Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
Reports
FY2025-Q2 Financial report (Jul. 1-Sep. 30, 2025)
by JCR Pharmaceuticals
Corporate governance report
by JCR Pharmaceuticals
FY2025 first quarter results conference call script
by JCR Pharmaceuticals
Corporate governance report
by JCR Pharmaceuticals
Consolidated financial results for the three months ended June 30, 2025 (FY2025)
by JCR Pharmaceuticals
FY2025 first quarter results conference call
by JCR Pharmaceuticals
Notice regarding the completion of payment for the disposition of treasury stock as restricted stock compensation
by JCR Pharmaceuticals
Notice of resolutions passed at the 50th ordinary general meeting of shareholders
by JCR Pharmaceuticals
Matters concerning controlling shareholders (affiliated companies)
by JCR Pharmaceuticals
Notice regarding the disposition of treasury stock as restricted stock compensation
by JCR Pharmaceuticals
1
2
3
4
5
Privacy Preference Center
Privacy Preferences
